Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancers - Small Intestine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06131398
What this trial is testing

AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Amgen 77
Testing effectiveness (Phase 2)Looking for participantsNCT07202364
What this trial is testing

YL202 in Patients With Advanced Solid Tumors

Who this might be right for
Non Small Cell Lung CancerColorectal CancerCervical Cancer+1 more
MediLink Therapeutics (Suzhou) Co., Ltd. 100
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Not applicableUnknownNCT04789252
What this trial is testing

Heterogeneity of Dendritic Cells in Colon and Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University of Milano Bicocca 64
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Not applicableStudy completedNCT01598597
What this trial is testing

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

Who this might be right for
Breast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more
Genentech, Inc. 276
Early research (Phase 1)Study completedNCT00004879
What this trial is testing

Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer

Who this might be right for
Colorectal CancerEsophageal CancerKidney Cancer+3 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Not applicableStudy completedNCT00427804
What this trial is testing

Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption

Who this might be right for
Rheumatoid ArthritisCrohn's Disease
Atlanta VA Medical Center 9
Early research (Phase 1)Study completedNCT03195699
What this trial is testing

Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers

Who this might be right for
Breast CancerHead and Neck Squamous Cell CarcinomaNon Small Cell Lung Cancer+5 more
Tvardi Therapeutics, Incorporated 64
Early research (Phase 1)Looking for participantsNCT07646106
What this trial is testing

THE-0504 in Patients With Solid Tumors

Who this might be right for
Small Cell Lung Cancer (SCLC)Colorectal Carcinoma (CRC)Gastric Cancer (GC)+2 more
Thena Biotech S.r.l. 30
Not applicableNo Longer AvailableNCT03554434
What this trial is testing

An Expanded Access Program for AM0010 (Pegilodecakin)

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company
Testing effectiveness (Phase 2)Active Not RecruitingNCT03485209
What this trial is testing

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Who this might be right for
Colorectal NeoplasmsCarcinoma, Non-Small-Cell LungExocrine Pancreatic Cancer+1 more
Seagen, a wholly owned subsidiary of Pfizer 350
Not applicableActive Not RecruitingNCT05038254
What this trial is testing

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Who this might be right for
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+42 more
M.D. Anderson Cancer Center 750
Early research (Phase 1)Active Not RecruitingNCT05277766
What this trial is testing

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+5 more
University Hospital, Ghent 45
Early research (Phase 1)Study completedNCT00441337
What this trial is testing

MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Who this might be right for
Carcinoma, Non-Small-Cell LungColorectal CancerMalignant Melanoma+2 more
Bristol-Myers Squibb 39
Testing effectiveness (Phase 2)UnknownNCT03221400
What this trial is testing

PEN-866 in Patients With Advanced Solid Malignancies

Who this might be right for
CarcinomaEndometrial AdenocarcinomaNeoplasms+16 more
Tarveda Therapeutics 340
Early research (Phase 1)Looking for participantsNCT06043466
What this trial is testing

A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophagus CancerGastric Cancer+4 more
Chongqing Precision Biotech Co., Ltd 30
Next Page